Bacil Pharma shareholders and shareholding pattern
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Bacil Pharma Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹19.36up ₹0.02 (0.10%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹19.34.
28 Oct: open ₹20.29, high ₹20.29, low ₹18.38
52-week range of traded prices to 28 Oct 2026
₹10.65Low, 26 Aug 2026₹61.80High, 10 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹28 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 1.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 12,111
Bacil Pharma's shareholding pattern for Sep 2026, filed on 16 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Bacil Pharma, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- PromotersNone
- Individuals and others100.00%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.69% | 44.69% | 44.69% | 44.69% | 44.69% | 44.35% | 44.35% | 44.35% | 44.35% | 44.35% | 44.35% | 45.09% | 45.09% | 45.09% | 45.09% | 45.09% | 45.09% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 20.70% | 10.60% | 0.20% | 0.20% | 0.08% | 0.08% | None | None | None | |
| Indian promoters | 44.69% | 44.69% | 44.69% | 44.69% | 44.69% | 44.35% | 44.35% | 44.35% | 44.35% | 44.35% | 44.35% | 45.09% | 45.09% | 45.09% | 45.09% | 45.09% | 45.09% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 42.67% | 20.70% | 10.60% | 0.20% | 0.20% | 0.08% | 0.08% | – | – | – |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 55.31% | 55.31% | 55.31% | 55.31% | 55.31% | 55.65% | 55.65% | 55.65% | 55.65% | 55.65% | 55.65% | 54.91% | 54.91% | 54.91% | 54.91% | 54.91% | 54.91% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 57.33% | 79.30% | 89.40% | 99.80% | 99.80% | 99.92% | 99.92% | 100.00% | 100.00% | 100.00% |
| Shares in issue | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 58,90,000 | 1,43,53,000 | 1,43,53,000 | 1,43,53,000 | 1,43,53,000 | 1,43,53,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 90,000 | 90,000 | 0 | 0 | 0 | 0 | – | – | – | – | – | – | – | – | – | 6,64,801 | 91,27,801 | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “None” is a filing that names no promoter holding shares. “Under 0.01%” is a holding of shares too small to show at two decimals.
Largest public holders of Bacil Pharma, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VICKY PRATAPBHAI SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.14% | 2.14% | 16.59% | 16.59% | 16.59% |
| NIKITA HIREN PATELResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 19.44% | 19.44% | 19.44% | 10.07% | 9.58% |
| MANUBHAI AMRUTLAL SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.75% | 1.75% | 1.75% | 18.30% | 18.30% | 18.34% | 9.86% | 7.84% |
| CHHAYA GAURANG SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.43% | 4.37% | 1.81% | 1.81% | 6.42% | 6.66% | 6.39% |
| JR SEAMLESS PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.49% |
| MANMOHAN JAGDISHPRASAD GHUWALEWALAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.18% | 4.18% | 4.18% | 4.18% | 4.18% |
| NAVIN KESHRIMAL MEHTAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | 1.05% | 1.05% | 2.17% | 2.17% | 2.17% | 2.17% | 2.17% |
| SHRYNAX TRADING PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.09% |
| PURSHOTTAM R BOHRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | 1.85% | 1.85% | – | 1.05% | 1.05% | 1.05% | – | – | – | – | 2.05% |
| BRENLEY ENGINEERS PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.78% |
| DEEPA NAVIN MEHTAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.74% | 1.74% | 1.74% | 1.74% | 1.74% |
| AMNESTI MULTISERVICES PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.43% |
| SAROJ KISHOR MEHTAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.82% | 2.82% | 2.82% | 1.16% | 1.16% | 1.16% | 1.16% | 1.16% |
| NIRAJ RAJNIKANT SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.44% | – |
| Vishal Mahesh WaghelaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.09% | – |
| HEMANG RAJENDRA DOSHIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.71% | 1.72% | – |
| DINESH ISHVARBHAI LALWANIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – |
| DHRUMIL RAKESH PATELResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.67% | 2.67% | 1.10% | 1.10% | 1.05% | – | – |
| GB HOSPITALITY INDIA PVT LTDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.49% | – | – | 14.46% | – | – | – |
| GB HOSPITALITY INDIACompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.49% | – | 8.49% | 14.46% | – | – | – | – |
| GB LOGISTICS COMMERCE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.23% | – | – | – | – | – |
| RANDEEP SINGH .Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.84% | 2.04% | 2.04% | – | – | – | – | – |
| MUKESHKUMAR HIRALAL PATELResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.98% | 1.98% | – | – | – | – | – |
| YOGESH PRASANLAL DAGLIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.36% | 1.36% | – | – | – | – | – |
| PATEL JAYESH NATVARLALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.27% | 1.31% | 1.33% | – | – | – | – | – |
| PARAS MANUBHAI SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.25% | – | – | – | – | – |
| PATEL HIMAXI RAKESHBHAIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.10% | 1.10% | – | – | – | – | – |
| GB LOGISTICSCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.08% | 6.58% | – | – | – | – | – | – |
| YELLOWSTONE VENTURES LLPCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | – | – | – | – | – | – |
| MUMBAI STOCK BROKERS PVT. LTDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.15% | – | – | – | – | – | – | – |
| PARIKSHIT K NOTARIAResident individuals, over ₹2 lakh at face value | – | 2.38% | 2.38% | 2.50% | 2.69% | 2.82% | 2.82% | 2.82% | 2.82% | 2.82% | 2.82% | 2.82% | 2.82% | 2.82% | – | – | – | – | – | – | – | – | – |
| PURUSHOTAM R BOHRA HUFOther non-institutions | – | – | – | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | – | – | – | – | – | – | – | – | – |
| PURUSHOTAM BOHRA HUFResident individuals, over ₹2 lakh at face value | – | – | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| VENTURA SECURITIES LIMITEDOther non-institutions | 2.47% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: NIRAJ RAJNIKANT SHAH no longer named, from 6.44%; JR SEAMLESS PRIVATE LIMITED newly named at 5.49%; SHRYNAX TRADING PRIVATE LIMITED newly named at 2.09%; 9 more moved